Holen Sie sich die Stockscreener-App
32.65
2.67%
0.85
Atricure Inc Aktie (ATRC) Neueste Nachrichten
Whale Trades: What are AtriCure Inc.’s recent SEC filings showing2025 Sector Review & Real-Time Volume Triggers - mfd.ru
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Atricure (ATRC) and Inspire Medical Systems (INSP) - The Globe and Mail
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
AtriCure's (ATRC) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Needham Reiterates AtriCure (ATRC) Buy Rating with $45 Price Tar - GuruFocus
Needham reiterates Buy rating on AtriCure stock amid competition By Investing.com - Investing.com India
Needham reiterates Buy rating on AtriCure stock amid competition - Investing.com
AtriCure stock maintains Market Outperform rating at Citizens despite Edwards competition By Investing.com - Investing.com South Africa
AtriCure stock maintains Market Outperform rating at Citizens despite Edwards competition - Investing.com India
(ATRC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
JPMorgan downgrades AtriCure stock rating to Neutral on Edwards competition - Investing.com Nigeria
Sector Update: Health Care Stocks Rise Late Afternoon - marketscreener.com
Top Midday Decliners - marketscreener.com
AtriCure (ATRC) Shares Fall 15% Following JPMorgan Downgrade - GuruFocus
AtriCure (NASDAQ:ATRC) Shares Gap Down After Analyst Downgrade - MarketBeat
Is AtriCure Inc. a top pick in the sectorMarket Activity Report & Growth Focused Investment Plans - mfd.ru
AtriCure (NASDAQ:ATRC) Rating Lowered to Neutral at JPMorgan Chase & Co. - MarketBeat
JPMorgan Downgrades AtriCure to Neutral From Overweight, Adjusts PT to $36 From $48 - marketscreener.com
Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
AtriCure (ATRC) Projected to Post Earnings on Tuesday - MarketBeat
Profit Review: Is AtriCure Inc a potential multi baggerJuly 2025 News Drivers & Consistent Return Strategy Ideas - baoquankhu1.vn
First Week of March 20th Options Trading For AtriCure (ATRC) - Nasdaq
AtriCure (NASDAQ:ATRC) Stock Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Wave Life Sciences (WVE) and Arcellx Inc (ACLX) - The Globe and Mail
AtriCure, Inc. (ATRC) Stock Analysis: A Compelling 43% Upside Potential For Investors - DirectorsTalk Interviews
AtriCure stock maintains Overweight rating at Piper Sandler on BoxX-NoAF potential - Investing.com India
AtriCure stock maintains Overweight rating at Piper Sandler on BoxX-NoAF potential By Investing.com - Investing.com South Africa
(ATRC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Local public company secures incentive for $45M project, likely to create hundreds of jobs - WKRC
Income Plays: Is AtriCure Inc a cyclical or defensive stock2025 Technical Patterns & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Weekly Recap: Will ARS Pharmaceuticals Inc announce a stock splitJuly 2025 Outlook & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Red-hot medical device firm gets big JobsOhio grant for $45M expansion - The Business Journals
Reasons to Retain Avanos Medical Stock in Your Portfolio Now - sharewise.com
When Will AtriCure, Inc. (NASDAQ:ATRC) Turn A Profit? - 富途牛牛
Market Wrap: Does AtriCure Inc have declining or rising EPSJuly 2025 Technicals & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Riverwater Partners LLC Buys 26,657 Shares of AtriCure, Inc. $ATRC - MarketBeat
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results - Chartmill
The Zacks Analyst Blog Highlights AtriCure, REV Group, Oceaneering International and Analog Devices - Yahoo Finance
Market Pulse: Is AtriCure Inc stock trending bullish2025 Investor Takeaways & Real-Time Volume Spike Alerts - baoquankhu1.vn
SG Americas Securities LLC Has $824,000 Position in AtriCure, Inc. $ATRC - MarketBeat
(ATRC) Risk Channels and Responsive Allocation - Stock Traders Daily
AtriCure, Inc. (ATRC) Stock Analysis: A Promising 35% Upside Potential Amid Strong Buy Ratings - DirectorsTalk Interviews
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
AtriCure (ATRC) Is Down 5.8% After Issuing 2026 Profitability Guidance And Expanding Credit Facility - Yahoo Finance
What are AtriCure Incs recent SEC filings showingMarket Growth Review & Long-Term Safe Return Strategies - baoquankhu1.vn
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results - Prime Publishers, Inc.
AI Diagnostics: The End of the High-Cost Imaging Era - GlobeNewswire
AtriCure Stock (+11%): Profitability Inflection Ignites Re-Rate - Trefis
AtriCure (NASDAQ:ATRC) Trading 6.7% HigherHere's Why - MarketBeat
AtriCure Inc (ATRC) Shares Up 8.49% on Jan 15 - GuruFocus
AtriCure CEO Touts $10B AFib and Pain Market, Raises EBITDA Outlook at JPMorgan Conference - MarketBeat
Momentum Shift: Is AtriCure Inc a potential multi baggerRate Cut & Reliable Price Action Trade Plans - baoquankhu1.vn
ATRC: Innovation and clinical evidence drive growth in AFib and pain management, with strong financial results - TradingView
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Boston Scientific (BSX) - The Globe and Mail
Street Watch: What is AtriCure Incs revenue forecastBear Alert & Low Risk Investment Opportunities - baoquankhu1.vn
AtriCure reports 13% revenue growth in Q4 2025, provides 2026 outlook - Investing.com Nigeria
AtriCure (NASDAQ:ATRC) Shares Down 7.6%Time to Sell? - MarketBeat
0.53%
1.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):